GlassScriptPhysician profile
Parker M Gennett
NPI 1467450429
$3,024.08
in general payments reported to CMS, 2019-2025
23 companies · $301 in 2025
The $301 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.67 · 2020: $18.93 · 2021: $166 · 2022: $231 · 2023: $73.68 · 2024: $2,142 · 2025: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,510 · Food and Beverage: $1,007.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,510.23 |
| Food and Beverage | $1,006.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $1,891.67 | 2024 | |
| Smith+Nephew, INC. | $154.71 | 2022-2025 | Grafix Pl, Oasis, Oasis Micro |
| Integra Lifesciences Corporation | $131.95 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Baxter Healthcare | $113.07 | 2024 | Floseal |
| Heron Therapeutics, INC. | $104.61 | 2021-2022 | |
| Axogen | $98.09 | 2021-2024 | Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Organogenesis INC. | $78.89 | 2019-2024 | |
| Advanced Oxygen Therapy INC. | $71.90 | 2020-2023 | Topical Oxygen Chamber For Extremities |
| Convatec INC. | $68.05 | 2025 | |
| Ethicon US, LLC | $44.36 | 2025 | Stratafix, Ethicon |
| Pacira Pharmaceuticals Incorporated | $34.06 | 2022-2025 | Exparel |
| Nevro Corp. | $31.81 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $28.49 | 2022-2023 | Seglentis |
| Merck Sharp & Dohme LLC | $23.57 | 2019 | |
| Tactile Systems Technology INC | $22.54 | 2024 | Flexitouch Plus, Entre Plus |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $18.16 | 2024 | Triluron, Hyalgan, Hymovis |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.87 | 2021 | |
| Curonix LLC | $17.73 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Mimedx Group, INC. | $15.12 | 2025 | |
| Ibsa Pharma INC. | $15.07 | 2025 | Tirosint, Licart, Flector |
| Baudax Bio INC. | $14.72 | 2021 | |
| Paratek Pharmaceuticals, INC. | $14.40 | 2024 | Nuzyra |
| Bioventus LLC | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parker Gennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.